You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0257 Quantitative analysis of severe intestinal involvements by serum fibroblast growth factor (FGF) 19 and 13C-fatty acid-breath test in patients with systemic sclerosis

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Scleroderma, myositis and related syndromes – clinical aspects and treatment
FRI0257 Quantitative analysis of severe intestinal involvements by serum fibroblast growth factor (FGF) 19 and 13C-fatty acid-breath test in patients with systemic sclerosis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Endo H, Yamamoto T, Kusunoki Y, et al
FRI0257 Quantitative analysis of severe intestinal involvements by serum fibroblast growth factor (FGF) 19 and 13C-fatty acid-breath test in patients with systemic sclerosis
Annals of the Rheumatic Diseases 2013;71:401.